1. Home
  2. DHC vs PCRX Comparison

DHC vs PCRX Comparison

Compare DHC & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Diversified Healthcare Trust of Beneficial Interest

DHC

Diversified Healthcare Trust of Beneficial Interest

HOLD

Current Price

$5.66

Market Cap

1.1B

Sector

Real Estate

ML Signal

HOLD

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$20.72

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DHC
PCRX
Founded
1998
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
DHC
PCRX
Price
$5.66
$20.72
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$5.75
$35.33
AVG Volume (30 Days)
1.6M
1.0M
Earning Date
02-24-2026
02-26-2026
Dividend Yield
0.71%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.47
Revenue
$1,537,901,000.00
$716,791,000.00
Revenue This Year
$4.79
$6.21
Revenue Next Year
$3.64
$8.26
P/E Ratio
N/A
$43.86
Revenue Growth
4.10
3.14
52 Week Low
$2.00
$18.80
52 Week High
$6.06
$27.64

Technical Indicators

Market Signals
Indicator
DHC
PCRX
Relative Strength Index (RSI) 61.62 36.78
Support Level $5.29 $18.80
Resistance Level $6.06 $21.12
Average True Range (ATR) 0.21 1.27
MACD 0.03 -0.42
Stochastic Oscillator 62.50 25.00

Price Performance

Historical Comparison
DHC
PCRX

About DHC Diversified Healthcare Trust of Beneficial Interest

Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. It operates through two segments: Office Portfolio and SHOP. The office portfolio includes medical office properties leased to medical-related businesses and life sciences properties. The SHOP segment runs communities that offer multiple types of residential care, ranging from independent living to nursing services. DHT operates across the United States and the majority of its revenue derives from rents and medical programs. Majority of revenue is from SHOP segment.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: